7 completed. 7 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Heat Therapy, Functional Capacity, and Vascular Health in Older Adults Home-based leg heat therapy, Home-based sham therapy - Aging Well, Walking, Difficulty | Phase 1 / Phase 2 | Completed | University of North Texas Health Science Center | 21 | 2022-11-03 | 2026-06-05 |
| VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C | Phase 2 / Phase 3 | Completed | Mandos LLC | 56 | 2015-10-01 | 2023-02-22 |
| Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty denosumab - Osteoarthritis, Hip, Ambulation Difficulty | Phase 2 | Completed | Hans Mallmin | 64 | 2012-08-07 | 2017-04-05 |
| Experimental Control Investigation of the Impact of Assistive Technology on the User-caregiver Dyad: a Multi-site Trial Assistive technology updating and tune up intervention - Mobility Limitations | Phase 2 | Completed | Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal | 88 | 2009-06-01 | 2014-02-19 |
| Effects of Game-based Balance Exercise for Older Adults With Fall History game-based balance exercises - Mobility Limitation | Phase 2 | Completed | University of Manitoba | 30 | 2007-08-01 | 2011-06-27 |
| Restoring Skill in Walking gait intervention - Mobility Limitation | Phase 2 | Completed | University of Pittsburgh | 48 | 2005-11-01 | 2007-12-13 |
| Increasing Physical Activity Among Overweight Women With Mobility Disabilities. Personalized exercise programme (PEP) - Obesity | Phase 2 | Completed | Centers for Disease Control and Prevention | 96 | 2004-10-01 | 2019-07-26 |
Cognitive Dysfunction (1) · Deglutition Disorders (1) · Disease (1) · Hyperemia (1) · Hyperthermia (1) · Motor Activity (1) · Niemann-Pick Disease, Type C (1) · Obesity (1) · Osteoarthritis, Hip (1)
Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Nutritional and Metabolic Diseases (2) · Arthritis (1) · Behavior (1) · Body Temperature Changes (1) · Body Weight (1) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1)
2-Hydroxypropyl-beta-cyclodextrin (1) · Cyclodextrins (1) · Denosumab (1)
Centers for Disease Control and Prevention (1) · Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal (1) · Hans Mallmin (1) · Mandos LLC (1) · University of Manitoba (1) · University of North Texas Health Science Center (1) · University of Pittsburgh (1)
United States (4) · Canada (2) · Australia (1) · France (1) · Germany (1) · New Zealand (1) · Singapore (1) · Spain (1) · Sweden (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Hans Mallmin, MD, PhD (1) · James Rimmer, Ph.D. (1) · Jessie VanSwearingen, PhD, PT (1) · Louise Demers, PhD (1) · Nils Hailer, MD, PhD (1) · Tony Szturm, BSc(PT), PhD (1)
PMID 19459233, PMID 21799138, PMID 22003158, PMID 31589776, PMID 40525490, PMID 40584156, PMID 41921101
2015 (1)